HSBC analyst Raj Sinha downgraded Integrated Diagnostics to Hold from Buy with a price target of 52c, down from 63c. The firm says kit prices have increased 50% year-over-year and that it does not see this passed on entirely thus far to customers. As such, the company’s margins will likely remain under pressure, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>